Smith, Benjamin A. H. http://orcid.org/0000-0001-8802-416X
Bertozzi, Carolyn R.
Article History
Accepted: 29 September 2020
First Online: 18 January 2021
Change Date: 8 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41573-021-00160-1
Competing interests
: C.R.B. is a co-founder of Redwood Bioscience, Enable Biosciences, Palleon Pharmaceuticals, InterVenn Bio, Lycia Therapeutics and OliLux Biosciences, and a member of the Board of Directors of Eli Lilly. B.A.H.S. is a shareholder of GlycoMimetics.
Free to read: This content has been made available to all.